Fig. 3From: Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER databaseOverall survival in the PSM cohort. a OS for patients treated with CRT and CT in whole cohort (N = 712); b OS for patients treated with CRT and CT in IHBDC cohort (N = 78); c OS for patients treated with CRT and CT in EHBDC cohort (N = 285); d OS for patients treated with CRT and CT in GBCA cohort (N = 349). PSM: Propensity-Score Matching; OS: overall survival; CRT: chemoradiotherapy; CT: chemotherapy; BTC: biliary tract cancers; IHBDC: intrahepatic bile duct cancer; EHBDC: extrahepatic bile duct cancer; GBCA: gallbladder cancer (GBCA)Back to article page